关注
George Goshua
George Goshua
在 yale.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
G Goshua, AB Pine, ML Meizlish, CH Chang, H Zhang, P Bahel, A Baluha, ...
The Lancet Haematology 7 (8), e575-e582, 2020
11442020
A neutrophil activation signature predicts critical illness and mortality in COVID-19
ML Meizlish, AB Pine, JD Bishai, G Goshua, ER Nadelmann, M Simonov, ...
Blood advances 5 (5), 1164-1177, 2021
2882021
Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes
CC Price, FL Altice, Y Shyr, A Koff, L Pischel, G Goshua, MM Azar, ...
Chest 158 (4), 1397-1408, 2020
240*2020
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ...
Science immunology 6 (59), eabh2259, 2021
1882021
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis
ML Meizlish, G Goshua, Y Liu, R Fine, K Amin, E Chang, N DeFilippo, ...
Am J Hematol 96 (4), 471-479, 2021
1842021
Circulating markers of angiogenesis and endotheliopathy in COVID-19
AB Pine, ML Meizlish, G Goshua, CH Chang, H Zhang, J Bishai, P Bahel, ...
Pulmonary Circulation 10 (4), 2045894020966547, 2020
1412020
Porous metal revision shells for management of contained acetabular bone defects at a mean follow-up of six years: a comparison between up to 50% bleeding host bone contact and …
A Sternheim, D Backstein, PRT Kuzyk, G Goshua, Y Berkovich, O Safir, ...
The Journal of Bone & Joint Surgery British Volume 94 (2), 158-162, 2012
632012
Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
G Goshua, P Sinha, JE Hendrickson, C Tormey, PK Bendapudi, AI Lee
Blood, The Journal of the American Society of Hematology 137 (7), 969-976, 2021
522021
Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses
MO Trépanier, AY Taha, RL Mantha, FA Ciobanu, QH Zeng, ...
Epilepsy research 99 (3), 225-232, 2012
372012
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol 7: e575–e582
G Goshua, AB Pine, ML Meizlish, CH Chang, H Zhang, P Bahel, A Baluha, ...
242020
Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura
G Goshua, A Gokhale, JE Hendrickson, C Tormey, AI Lee
Blood Advances 4 (3), 539-545, 2020
132020
Distributional cost-effectiveness of equity-enhancing gene therapy in sickle cell disease in the United States
G Goshua, C Calhoun, S Ito, LP James, A Luviano, L Krishnamurti, ...
Annals of internal medicine 176 (6), 779-787, 2023
122023
Adenovirus-based vaccines and thrombosis in pregnancy: a systematic review and meta-analysis
L Pischel, KM Patel, G Goshua, SB Omer
Clinical Infectious Diseases 75 (7), 1179-1186, 2022
112022
Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia
G Goshua, P Sinha, N Kunst, L Pischel, AI Lee, A Cuker
American journal of hematology 98 (1), 122-130, 2023
102023
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
JP Bewersdorf, KK Patel, G Goshua, RM Shallis, NA Podoltsev, ...
Blood, The Journal of the American Society of Hematology 139 (11), 1766-1770, 2022
9*2022
Evidence-Based Minireview: Should caplacizumab be used routinely in unselected patients with immune thrombotic thrombocytopenic purpura?
G Goshua, PK Bendapudi
Hematology 2022 (1), 491-494, 2022
62022
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study
S Stukas, G Goshua, A Kinkade, R Grey, G Mah, CM Biggs, S Jamal, ...
The Lancet Regional Health–Americas 11, 2022
52022
Immunothrombosis: a COVID‐19 concerto.
G Goshua, A Butt, AI Lee
British Journal of Haematology 194 (3), 2021
42021
VWF/ADAMTS13 ratios are potential markers of immunothrombotic complications in patients with COVID-19: a cross-sectional study
DV Madeeva, J Christian, G Goshua, HJ Chun, AI Lee, AB Pine
Blood 136, 34-35, 2020
42020
Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia
JP Bewersdorf, KK Patel, G Goshua, RM Shallis, NA Podoltsev, M Stahl, ...
Leukemia & lymphoma 64 (2), 454-461, 2023
32023
系统目前无法执行此操作,请稍后再试。
文章 1–20